Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:LCAV

LCA-Vision (LCAV) Stock Price, News & Analysis

About LCA-Vision Stock (NASDAQ:LCAV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Receive LCAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LCA-Vision and its competitors with MarketBeat's FREE daily newsletter.

LCAV Stock News Headlines

Buffett Dumps $982 Million in BofA Stock—What Does He Know?
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
LCAV Historical Data
Apple Vision Pro
See More Headlines

LCAV Stock Analysis - Frequently Asked Questions

LCA-Vision Inc. (NASDAQ:LCAV) announced its quarterly earnings results on Wednesday, April, 30th. The healthcare company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.24. The healthcare company earned $25.53 million during the quarter, compared to analysts' expectations of $32.04 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that LCA-Vision investors own include Gen Digital (GEN), Amyris (AMRS), American Superconductor (AMSC), Digital Turbine (APPS), Athersys (ATHX), AVEO Pharmaceuticals (AVEO) and Bloom Energy (BE).

Company Calendar

Last Earnings
4/30/2014
Today
11/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LCAV
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:LCAV) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners